Compare NAD & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NAD | NEOG |
|---|---|---|
| Founded | 1999 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | N/A | 1989 |
| Metric | NAD | NEOG |
|---|---|---|
| Price | $12.21 | $10.89 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.67 |
| AVG Volume (30 Days) | 595.7K | ★ 3.3M |
| Earning Date | 01-01-0001 | 01-08-2026 |
| Dividend Yield | ★ 4.35% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $880,319,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.67 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.56 | $3.87 |
| 52 Week High | $11.64 | $11.15 |
| Indicator | NAD | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 61.23 | 77.05 |
| Support Level | $11.97 | $10.37 |
| Resistance Level | $12.24 | $10.87 |
| Average True Range (ATR) | 0.09 | 0.43 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 97.30 | 82.64 |
Nuveen Quality Municipal Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide current income exempted from regular federal income tax by investing in tax-exempt municipal securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.